Journal
CELL METABOLISM
Volume 20, Issue 1, Pages 10-25Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.03.002
Keywords
-
Categories
Funding
- Ellison Medical Foundation
- NIH/NIA [1R01AG044346, 1F32AG044944]
Ask authors/readers for more resources
When energy supply is low, organisms respond by slowing aging and increasing resistance to diverse age-related pathologies. Targeting the mechanisms underpinning this response may therefore treat multiple disorders through a single intervention. Here, we discuss AMP-activated protein kinase (AMPK) as an integrator and mediator of several pathways and processes linking energetics to longevity. Activated by low energy, AMPK is both prolongevity and druggable, but its role in some pathologies may not be beneficial. As such, activating AMPK may modulate multiple longevity pathways to promote healthy aging, but unlocking its full potential may require selective targeting toward substrates involved in longevity assurance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available